AMP 2026 has ended. This guide stays up as the record of who was there. Next: AMP 2027, Nov 9–13, 2027 in Baltimore

Natera at AMP 2026

Nov 10–14, 2026 Seattle, WA ~2k attendees Website

Natera brings 2 presentations to AMP 2026 in Seattle, and exhibits at Booth 445. Its workshop covers advances in molecular residual disease testing and the expanding role of digital pathology and artificial intelligence, and a poster predicts comprehensive genomic profiling failure from H&E images. The company runs cell-free DNA testing, including a custom circulating tumor DNA test for residual disease and treatment monitoring.

OrganizationAMP 2026 Attendance
Natera
San Carlos, CA
Diagnostics
Cell-free DNA testing company; Signatera is a custom ctDNA test for molecular residual disease assessment and treatment monitoring.
Booth
Exhibiting at Booth 445
Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm
Workshop
Wed, Nov 11
4:00pm–4:50pm
Title: Advancements in MRD Testing: The Expanding Role of Digital Pathology and AI
Digital pathology and machine learning applied to specimen assessment and interpretation in residual disease testing.

Explore the full AMP 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Seattle. Leave your work email and we’ll be in touch.

Privacy

Download the full AMP 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Natera

Tell us what you sell and we’ll find the people at Natera most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction